Serodiagnosis of primary infections with human parvovirus 4, Finland.
Lahtinen A., Kivelä P., Hedman L., Kumar A., Kantele A., Lappalainen M., Liitsola K., Ristola M., Delwart E., Sharp C., Simmonds P., Söderlund-Venermo M., Hedman K.
To determine the prevalence of parvovirus 4 infection and its clinical and sociodemographic correlations in Finland, we used virus-like particle-based serodiagnostic procedures (immunoglobulin [Ig] G, IgM, and IgG avidity) and PCR. We found 2 persons with parvovirus 4 primary infection who had mild or asymptomatic clinical features among hepatitis C virus-infected injection drug users.